Citation

Elias (Lou) K. Halvas, A. Wiegand, Valerie F. Boltz, Mary Kearney, Dwight V. Nissley, Michael Wantman, Scott M. Hammer, Sarah Palmer, Florin Vaida, John Coffin, John W. Mellors. Low frequency NNRTI-resistant variants contribute to failure of efavirenz-containing regimens in treatment-experienced patients. Journal of Infectious Diseases. 2010. 201: 672-80. PMID: 20102272

Citation

Marisa T. Tungsiripat, Doug Kitch, Marshall Jay Glesby, Samir K. Gupta, John W. Mellors, Laura E. Moran, Lynne Jones, Beverly L. Alston-Smith, James F. Rooney, Judith A. Aberg. A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206. AIDS. 2010. 24: 1781-4. PMID: 20495438

Citation

Carl J. Fichtenbaum, Tzu-min Yeh, Scott Evans, Judith A. Aberg. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087. Journal of Clinical Lipidology. 2010. 4: 279-87. PMID: 20824151

Citation

Homer L. Twigg, Carol T Schnizlein Bick, Michael D. Weiden, Fred T. Valentine, L. Joseph Wheat, Richard B. Day, Helen C. Rominger-Grubbs, Lu (Summer) Zheng, Ronald G. Collman, Robert W. Coombs, R. Pat Bucy, Naser L. Rezk, Angela D.M. Kashuba. Measurement of antiretroviral drugs in the lungs of HIV-infected patients. HIV Therapy. 2010. 4: 247-51. PMID: 20436781

Citation

Judith J. Lok, Ronald J. Bosch, Constance A. Benson, Ann C. Collier, Gregory K. Robbins, Robert Shafer. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS. 2010. 24: 1867-76. PMID: 20467286

Citation

Lori Kamemoto, Susan Ellen Cohn, Mary A. Vogler, Kristine Patterson, Lori Kamemoto, Jeong-Gun Park, Heather D. Watts, Francesca Aweeka, Karin L. Klingman, Apsara Nair, Song Yu, Susan Ellen Cohn. Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188. Journal of Acquired Immune Deficiency Syndromes. 2010. 55: 473-82. PMID: 20842042

Citation

Tzu-min Yeh, Scott Evans, Roy (Trip) Gulick, David B. Clifford. Vicriviroc and peripheral neuropathy: results from AIDS Clinical Trials Group 5211.. HIV Clinical Trials. 2010. 11: 51-8. PMID: 20400411

Citation

Roger Paredes, Christina M. Lalama, Heather Ribaudo, Bruce R. Schackman, Cecilia M. Shikuma, Francoise Giguel, William A. Meyer, Victoria A. Johnson, Susan A. Fiscus, Richard T. D'Aquila, Roy (Trip) Gulick, Daniel R. Kuritzkes. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.. Journal of Infectious Diseases. 2010. 201: 662-71. PMID: 20102271

Citation

Philip Grant, Lauren Komarow, Janet Andersen, Irini Sereti, Savita G. Pahwa, Michael M. Lederman, Joseph J. Eron, Ian M. Sanne, William G. Powderly, Evelyn Hogg, Carol Suckow, Andrew R. Zolopa. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection.. Public Library of Science One. 2010. 5: e11416. PMID: 20617176

Citation

Early antiretroviral therapy for patients with acute AIDS-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164. HIV Clinical Trials. 2010. 11: 248-59. PMID: 21126955